proteon20therapeutics2c20inc.  (PRTO) - nasdaqgm

  Revenue / EPS Summary *  
 
 Fiscal Quarter 2017
(Fiscal Year)
2016
(Fiscal Year)
2015
(Fiscal Year)
March      
   Revenue      
   EPS -0.39 (3/31/2017) -0.4 (3/31/2016) -0.28 (3/31/2015)
   Dividends      
June      
   Revenue      
   EPS -0.33 (6/30/2017) -0.47 (6/30/2016) -0.31 (6/30/2015)
   Dividends      
September      
   Revenue      
   EPS -1.1 (9/30/2017) -0.43 (9/30/2016) -0.32 (9/30/2015)
   Dividends      
December  (FYE)      
   Revenue      
   EPS -0.31 (12/31/2017) -0.42 (12/31/2016) -0.39 (12/31/2015)
   Dividends      
Totals      
   Revenue N/A N/A N/A
   EPS -2.13 -1.72 -1.3
   Dividends N/A N/A N/A
   Previous 3 Years
 
 
©2018, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.